AIEgens/Mitochondria Nanohybrids as Bioactive Microwave Sensitizers for Non‐Thermal Microwave Cancer Therapy
Xinghua Yu,Ming Lyu,Xupei Ou,Wenquan Liu,Xing Yang,Xiaoxi Ma,Tianfu Zhang,Longnan Wang,Ying‐Chuan Zhang,Sijie Chen,Ryan T. K. Kwok,Zheng Zheng,Hong‐Liang Cui,Lintao Cai,Pengfei Zhang,Ben Zhong Tang
DOI: https://doi.org/10.1002/adhm.202202907
IF: 10
2023-02-19
Advanced Healthcare Materials
Abstract:A bioactive AIE nanohybrid based on the integration of mitochondria targeting AIEgen (DCPy) and living mitochondria is developed for non‐thermal microwave cancer therapy with deep penetration ability. Under microwave irradiation, the nanohybrid could generate reactive oxygen species (ROS) inducing tumor apoptosis and letting cancer cells retrieve the metabolic functions of normal cells. Aggregation‐induced emission luminogens (AIEgens) are widely used as photosensitizers for image‐guided photodynamic therapy (PDT). Due to the limited penetration depth of light in biological tissues, the treatments of deep‐seated tumors by visible‐light‐sensitized aggregation‐induced emission (AIE) photosensitizers are severely hampered. Microwave dynamic therapy attracts much attention because microwave irradiation can penetrate very deep tissues and sensitize the photosensitizers to generate reactive oxygen species (ROS). In this work, a mitochondrial‐targeting AIEgen (DCPy) is integrated with living mitochondria to form a bioactive AIE nanohybrid. This nanohybrid can not only generate ROS under microwave irradiation to induce apoptosis of deep‐seated cancer cells but also reprogram the metabolism pathway of cancer cells through retrieving oxidative phosphorylation (OXPHOS) instead of glycolysis to enhance the efficiency of microwave dynamic therapy. This work demonstrates an effective strategy to integrate synthetic AIEgens and natural living organelles, which would inspire more researchers to develop advanced bioactive nanohybrids for cancer synergistic therapy.
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials